Texas MPJE Practice Examination
Questions And Correct Answers (Verified
Answers) Plus Rationales 2026 Q&A |
Instant Download Pdf
1. A pharmacist receives a prescription for a Schedule II controlled substance
that is missing the prescriber’s DEA registration number. The pharmacist
contacts the prescriber’s office, and the medical assistant provides the DEA
number verbally. Which action is most appropriate under Texas and federal
law?
A. Accept the verbal DEA number and document the conversation on the
prescription.
B. Refuse to fill the prescription and return it to the patient.
C. Fill the prescription based on the verbal DEA number only if the
prescriber is a physician.
D. Fill the prescription after verifying the DEA number through the DEA’s
online database.
Answer: A
*Rationale: Under 21 CFR 1306.05, a prescription for a controlled substance must
contain the prescriber’s DEA registration number. Texas Administrative Code (TAC)
§ 291.31 allows a pharmacist to add or correct missing information, including the
DEA number, if the pharmacist obtains the information directly from the
prescriber. Verbal confirmation from the prescriber’s office staff is acceptable if
documented, but the pharmacist must exercise professional judgment to verify the
authenticity. Option B is too restrictive because the deficiency can be corrected.
Option C incorrectly limits the correction to physicians only. Option D is not a legal
requirement; the DEA database is not a public verification tool for routine
prescriptions.
, 2. A pharmacy technician in Texas accidentally dispenses a Schedule III drug to
the wrong patient. The error is discovered 10 minutes later, and the patient
has not yet left the pharmacy parking lot. What is the pharmacist’s primary
responsibility immediately upon discovery?
A. Notify the Texas State Board of Pharmacy (TSBP) within 24 hours.
B. Complete a medication incident report and file it with the pharmacy’s
quality assurance committee.
C. Retrieve the medication from the patient, document the error, and
counsel the patient on the correct medication.
D. Dispense the correct medication and destroy the returned medication in
the presence of the patient.
Answer: C
*Rationale: The pharmacist’s immediate duty is patient safety—retrieving the
incorrect medication, providing the correct one, and counseling the patient to
prevent harm. TAC § 291.33 requires reporting of medication errors to the TSBP
only if the error caused or could have caused serious harm or death; a simple
retrieval does not mandate immediate board notification unless it meets that
threshold. Option B is a secondary step, not the primary action. Option D is
incorrect because the returned medication must be quarantined and not destroyed
on the spot without proper documentation and witness protocols.
3. A pharmacist in Texas receives a prescription for amoxicillin 500 mg for a 4-
year-old child. The prescription is written for 1 tablet three times daily for
10 days, but the pharmacist’s clinical judgment indicates the dose exceeds
the recommended maximum for the child’s weight. What is the
pharmacist’s most appropriate course of action?
A. Dispense the medication as written, because the pharmacist cannot
change the prescriber’s dose.
B. Contact the prescriber to verify the dose and, if necessary, suggest a
weight-based adjustment.
C. Reduce the dose to a pediatric safe amount and document the change.
D. Refuse to fill the prescription and refer the patient to the emergency
room.
,Answer: B
*Rationale: Under TSBP rules and the standard of care, a pharmacist has a duty to
ensure a prescription is therapeutically appropriate. If a dose appears excessive,
the pharmacist must contact the prescriber to clarify and recommend an
adjustment. Option A is negligent because the pharmacist cannot blindly dispense
a potentially toxic dose. Option C is illegal because pharmacists in Texas cannot
independently change the dose of a prescription without prescriber authorization,
except in specific hospital settings with protocols. Option D is overly drastic unless
the prescriber cannot be reached and the risk is imminent.
4. According to the Texas Dangerous Drug Act, which of the following
substances is classified as a dangerous drug, requiring a prescription for
dispensing?
A. Insulin
B. Pseudoephedrine
C. Hydrocodone combination products
D. Albuterol sulfate
Answer: D
*Rationale: Albuterol sulfate is a dangerous drug under Texas law (Texas Health
and Safety Code § 483.001), meaning it requires a prescription. Insulin is exempt
from the Dangerous Drug Act if it is sold over-the-counter for diabetic
management. Pseudoephedrine is not a dangerous drug but a Schedule V
controlled substance and also regulated under the Combat Methamphetamine
Epidemic Act. Hydrocodone combination products are Schedule II controlled
substances, not classified under the Dangerous Drug Act as they fall under the
Controlled Substances Act.
5. A pharmacist is asked by a patient to transfer a prescription for a Schedule
IV drug from their pharmacy to another pharmacy in Texas. The original
prescription has two refills remaining. Which of the following is true
regarding this transfer?
A. The transfer must be done by the pharmacist or pharmacy technician and
documented.
, B. The transferring pharmacy must cancel the original prescription in their
system but may retain a hard copy.
C. The transfer is valid only if the patient is present at the receiving
pharmacy to pick it up.
D. The receiving pharmacy must verify the prescriber’s DEA number before
accepting the transfer.
Answer: B
*Rationale: Under 21 CFR 1306.25, a Schedule IV prescription may be transferred
once between pharmacies. The transferring pharmacy must void the remaining
refills in their system but may keep a copy for records. Option A is incorrect
because only a licensed pharmacist may transfer controlled substance
prescriptions, not technicians. Option C is false; the patient does not need to be
present at the time of transfer. Option D is not a federal or Texas requirement for a
transfer; the receiving pharmacy relies on the transferring pharmacy’s verification.
6. In a Texas community pharmacy, a pharmacist delegates the responsibility
of final verification of a dispensed prescription to a pharmacy intern. Under
TSBP rules, which statement is correct?
A. The pharmacist may delegate final verification to an intern who has
completed 1,500 intern hours.
B. The pharmacist may not delegate final verification to an intern under any
circumstances.
C. The pharmacist may delegate final verification only if the intern is a final-
year student enrolled in an ACPE-accredited program.
D. The pharmacist may delegate final verification to an intern if the
pharmacist is physically present in the pharmacy.
Answer: B
*Rationale: Texas Administrative Code § 291.33 and § 291.34 explicitly state that
the final verification of a prescription, including the check of the drug, strength,
and patient, is a non-delegable duty of the pharmacist. This duty cannot be
delegated to interns or technicians regardless of their experience or education.
Questions And Correct Answers (Verified
Answers) Plus Rationales 2026 Q&A |
Instant Download Pdf
1. A pharmacist receives a prescription for a Schedule II controlled substance
that is missing the prescriber’s DEA registration number. The pharmacist
contacts the prescriber’s office, and the medical assistant provides the DEA
number verbally. Which action is most appropriate under Texas and federal
law?
A. Accept the verbal DEA number and document the conversation on the
prescription.
B. Refuse to fill the prescription and return it to the patient.
C. Fill the prescription based on the verbal DEA number only if the
prescriber is a physician.
D. Fill the prescription after verifying the DEA number through the DEA’s
online database.
Answer: A
*Rationale: Under 21 CFR 1306.05, a prescription for a controlled substance must
contain the prescriber’s DEA registration number. Texas Administrative Code (TAC)
§ 291.31 allows a pharmacist to add or correct missing information, including the
DEA number, if the pharmacist obtains the information directly from the
prescriber. Verbal confirmation from the prescriber’s office staff is acceptable if
documented, but the pharmacist must exercise professional judgment to verify the
authenticity. Option B is too restrictive because the deficiency can be corrected.
Option C incorrectly limits the correction to physicians only. Option D is not a legal
requirement; the DEA database is not a public verification tool for routine
prescriptions.
, 2. A pharmacy technician in Texas accidentally dispenses a Schedule III drug to
the wrong patient. The error is discovered 10 minutes later, and the patient
has not yet left the pharmacy parking lot. What is the pharmacist’s primary
responsibility immediately upon discovery?
A. Notify the Texas State Board of Pharmacy (TSBP) within 24 hours.
B. Complete a medication incident report and file it with the pharmacy’s
quality assurance committee.
C. Retrieve the medication from the patient, document the error, and
counsel the patient on the correct medication.
D. Dispense the correct medication and destroy the returned medication in
the presence of the patient.
Answer: C
*Rationale: The pharmacist’s immediate duty is patient safety—retrieving the
incorrect medication, providing the correct one, and counseling the patient to
prevent harm. TAC § 291.33 requires reporting of medication errors to the TSBP
only if the error caused or could have caused serious harm or death; a simple
retrieval does not mandate immediate board notification unless it meets that
threshold. Option B is a secondary step, not the primary action. Option D is
incorrect because the returned medication must be quarantined and not destroyed
on the spot without proper documentation and witness protocols.
3. A pharmacist in Texas receives a prescription for amoxicillin 500 mg for a 4-
year-old child. The prescription is written for 1 tablet three times daily for
10 days, but the pharmacist’s clinical judgment indicates the dose exceeds
the recommended maximum for the child’s weight. What is the
pharmacist’s most appropriate course of action?
A. Dispense the medication as written, because the pharmacist cannot
change the prescriber’s dose.
B. Contact the prescriber to verify the dose and, if necessary, suggest a
weight-based adjustment.
C. Reduce the dose to a pediatric safe amount and document the change.
D. Refuse to fill the prescription and refer the patient to the emergency
room.
,Answer: B
*Rationale: Under TSBP rules and the standard of care, a pharmacist has a duty to
ensure a prescription is therapeutically appropriate. If a dose appears excessive,
the pharmacist must contact the prescriber to clarify and recommend an
adjustment. Option A is negligent because the pharmacist cannot blindly dispense
a potentially toxic dose. Option C is illegal because pharmacists in Texas cannot
independently change the dose of a prescription without prescriber authorization,
except in specific hospital settings with protocols. Option D is overly drastic unless
the prescriber cannot be reached and the risk is imminent.
4. According to the Texas Dangerous Drug Act, which of the following
substances is classified as a dangerous drug, requiring a prescription for
dispensing?
A. Insulin
B. Pseudoephedrine
C. Hydrocodone combination products
D. Albuterol sulfate
Answer: D
*Rationale: Albuterol sulfate is a dangerous drug under Texas law (Texas Health
and Safety Code § 483.001), meaning it requires a prescription. Insulin is exempt
from the Dangerous Drug Act if it is sold over-the-counter for diabetic
management. Pseudoephedrine is not a dangerous drug but a Schedule V
controlled substance and also regulated under the Combat Methamphetamine
Epidemic Act. Hydrocodone combination products are Schedule II controlled
substances, not classified under the Dangerous Drug Act as they fall under the
Controlled Substances Act.
5. A pharmacist is asked by a patient to transfer a prescription for a Schedule
IV drug from their pharmacy to another pharmacy in Texas. The original
prescription has two refills remaining. Which of the following is true
regarding this transfer?
A. The transfer must be done by the pharmacist or pharmacy technician and
documented.
, B. The transferring pharmacy must cancel the original prescription in their
system but may retain a hard copy.
C. The transfer is valid only if the patient is present at the receiving
pharmacy to pick it up.
D. The receiving pharmacy must verify the prescriber’s DEA number before
accepting the transfer.
Answer: B
*Rationale: Under 21 CFR 1306.25, a Schedule IV prescription may be transferred
once between pharmacies. The transferring pharmacy must void the remaining
refills in their system but may keep a copy for records. Option A is incorrect
because only a licensed pharmacist may transfer controlled substance
prescriptions, not technicians. Option C is false; the patient does not need to be
present at the time of transfer. Option D is not a federal or Texas requirement for a
transfer; the receiving pharmacy relies on the transferring pharmacy’s verification.
6. In a Texas community pharmacy, a pharmacist delegates the responsibility
of final verification of a dispensed prescription to a pharmacy intern. Under
TSBP rules, which statement is correct?
A. The pharmacist may delegate final verification to an intern who has
completed 1,500 intern hours.
B. The pharmacist may not delegate final verification to an intern under any
circumstances.
C. The pharmacist may delegate final verification only if the intern is a final-
year student enrolled in an ACPE-accredited program.
D. The pharmacist may delegate final verification to an intern if the
pharmacist is physically present in the pharmacy.
Answer: B
*Rationale: Texas Administrative Code § 291.33 and § 291.34 explicitly state that
the final verification of a prescription, including the check of the drug, strength,
and patient, is a non-delegable duty of the pharmacist. This duty cannot be
delegated to interns or technicians regardless of their experience or education.
